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Editorial on the Research Topic
Machine Learning in Biomolecular Simulations
Interest in machine learning is growing in all fields of science, industry, and business. This interest
was not primarily initiated by new theoretical findings. Interestingly, the theoretical basis of the
majority of machine learning techniques, such as artificial neural networks, decision trees, or kernel
methods, have been known for a relatively long time. Instead, there are other effects that triggered
the recent boom of machine learning.
First, machine learning needs data to learn on. Huge data sets from Internet, Internet of Things,
social networks, phones, wearable devices, and other sources are now available. Such datasets were
not available a decade ago. Second, the recent wave of machine learning benefits from hardware
advances, in particular from computing on graphical processing units and specialized hardware.
Biomolecular modeling and simulations are an ideal field for the application ofmachine learning
approaches in the spirit of the recent boom of machine learning. Biomolecular simulations produce
large amounts of data in the form of trajectories that can be used to train machine learning
algorithms. At the same time, vast amounts of genomic data were critical in allowing AlphaFold in
leading the field of de novo protein prediction in the most recent CASP protein prediction round.
Moreover, GPUs are routinely used in biomolecular simulations for more than a decade to offload
critical parts of calculation.
This Research Topic collects eight innovative works showcasing the application of machine
learning in biomolecular simulations and related fields. It demonstrates major machine learning
approaches such as artificial neural networks, random forests, and non-linear dimensionality
reduction methods. These techniques are applied in analysis of trajectories, acceleration of
biomolecular simulations, parametrization of force fields, and other tasks.
Helfrecht et al. present an alternative to classical definitions of structural motifs in proteins.
Classical definitions of secondary and super-secondary structures are based on intuitive criteria,
such as hydrogen bonds, dihedral angles, and others and have been widely used. However, they
experience problems with borderline and partially disordered structures. This article presents
an alternative based on machine learning, namely on Probabilistic Analysis of Molecular Motifs
algorithm previously developed in the group.
The article from Trapl et al. presents a program Anncolvar. This tool makes it possible to
approximate a collective variable using a simple neural network. The choice of optimal collective
variables is crucial to the convergence of enhanced algorithms based on them. Anncolvar is
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shown to be very useful for collective variables that cannot
be explicitly calculated on-the-fly or computationally expensive
collective variables.
Wang et al. used classical as well as by unsupervised and
supervised machine learning methods (principal component
analysis, random forest) to analyze protein dynamics. They
analyzed trajectories of an enzyme linked to antibiotic resistance
β-lactamase, simulated in multiple conformational states.
Intrinsically disordered proteins (IDPs) are a hot topic given
that about 10% of all proteins are disordered, and about 40%
of eukaryotic proteins have at least one long disordered loop. It
has been shown that proteins can have a function despite not
having a stable conformation. This brings a new challenge in
analysis of dynamics. Grazioli et al. use machine learning and
network models on simulation trajectories of amyloid beta in
its wild type and its medicinally relevant mutant. They show
that machine learning analysis can explain the difference between
protein variants. This was not possible by conventional trajectory
analysis methods.
There is a growing number of works indicating that molecular
mechanics potentials (force fields) developed for compactly
folded proteins may fail in modeling of unfolded proteins
and especially IDPs. This fact motivated Demerdash et al. to
optimize force field for IDPs on the basis of data from small-
angle X-ray/neutron scattering. This was done by iterative
rounds of molecular dynamics simulations and comparison
with experimental data. This approach was demonstrated on
three IDPs.
The article of Agajanian et al. drives us more into the
bioinformatics area. Recent applications of next-generation
sequencing makes it possible to identify the role of mutations
associated with cancer. The authors integrated multiple
machine learning approaches to classify mutations an
the basis of nucleotide sequence. The approach is further
illustrated on biomolecular simulations of cancer associated
protein kinases.
Tribello and Gasparotto use unsupervised machine learning
methods to analyse simulation trajectories. Trajectory of the
C-terminal fragment of the immunoglobulin binding domain
B1 of protein G of Streptococcus was used as a model
trajectory and analyzed by a range of mostly non-linear
dimensionality reduction methods, namely principal component
analysis, distance matching, Laplacian eigenmaps, Isomap, tSNE,
and sketchmap. These methods are illustrated together with
clustering methods. The article provides an overview of these
methods and their advantages and disadvantages are discussed.
Kinetics of drug unbinding is recently becoming equivalently
or even more important than binding thermodynamics in
drug design as a parameter distinguishing between good and
bad compounds. The article of Kokh et al. addresses this
problem by machine learning. There are several trajectories
of spontaneous drug binding available in literature. Drug
unbinding is several orders of magnitude slower and today
cannot be simulated without enhanced sampling. The authors
analyzed a series of trajectories from enhanced sampling method
Random Accelerated Molecular Dynamics, in particular its
variant designed for simulation of drug unbinding kinetics. The
approach has been tested on a series of heat shock protein 90
ligands differing by four orders of magnitude in their unbinding
rates. Excellent agreement with experiment was obtained for
most classes of compounds.
We believe that the papers included in this Research
Topic demonstrate the great potential of machine learning in
all fields pertaining biomolecular modeling and simulations,
including in improving the accuracy of the models, in the
analysis of molecular simulations and in providing effective
variables to enhance the sampling. With this Research Topic
Frontiers in Molecular Biosciences aspires to become a key
forum for publishing of approaches combining machine
learning with biomolecular simulations and further promote this
multidisciplinary field.
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